http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110017936-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2baf849d216e689ecc40ccc931a7a7bc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
filingDate 2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb6b270ba9138860b1b8d5c47ece9194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_648a40298bfeedc051cc0fa71a270005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0686f1a0fcebf140fe8868802f74e4a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dae1453a79090fdf1082d8b1b0ea6ecc
publicationDate 2011-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20110017936-A
titleOfInvention Crystalline Forms of Quinoline Compounds and Methods for Making the Same
abstract Provided is a method for preparing a drug substance of crystalline pitavastatin calcium having excellent stability. In the preparation of the compound (Pitavastatin calcium) represented by the formula (1), the water content is adjusted to about 5 to 15%, and the crystalline form is controlled to be crystalline form A to obtain a drug substance having excellent stability.
priorityDate 2003-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447991592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2735067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452349496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453447712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515599

Total number of triples: 40.